Colorado Dangerous Drugs & Medical Devices

Fosamax®

Burg Simpson is not currently pursuing new Fosamax® cases.

Millions of Americans are prescribed Fosamax to help improve their bone density and fight osteoporosis. However, evidence suggests that Fosamax and its generic equivalent (alendronate), may actually be doing more harm than good and may be the cause of unusual and painful low-energy fractures of the femur (thigh bone).

FOSAMAX LINKED TO ATYPICAL FEMUR FRACTURES

Originally approved in 1995, Fosamax® is manufactured by Merck & Co, Inc. and belongs to a family of drugs know as bisphosphonates. Bisphosphonates are routinely prescribed to post-menopausal women and other individuals who are known to be at a high-risk of bone density deterioration.

In 2008, the results of an observational study, published in the Journal of Orthopedic Trauma, linked Fosamax® to a distinct type of fracture in the femur. The study of some 70 patients experiencing low-energy femur fractures (which occur when someone falls from a standing height or less) revealed that these patients all suffered a similar and distinct straight-line fracture of their femur. Furthermore, of the patients studied, more than a third had been taking Fosamax® for an average of five years or more.

PROLONGED USE OF FOSAMAX® MAY PUT WOMEN AT HIGHER RISK

Since the findings of that 2008 study, it would appear that orthopedic surgeons and bone specialists are continuing to see more and more of these unusual fractures among long-term users of Fosamax®, particularly in women. In February 2011, the results of a Canadian study, published in the online edition of the Journal of the American Medical Association suggested that women who had been on bisphosphonates such as Fosamax® for more than five years, had nearly three times higher risk of these unusual fractures than those with only transient exposure to the drugs.

FOSAMAX® AND OSTEONECROSIS OF THE JAW (ONJ; DEAD JAW)

In addition to causing potential femur fractures, prolonged use of Fosamax® and other bisphosphonates have long been linked to a rare condition that involves the loss, or breakdown, of the jaw bone called osteonecrosis of the jaw (ONJ) or dead jaw. In early 2005 the FDA requested that Merck and all other bisphosphonate manufacturers revise the Fosamax warning label to include a warning that their drugs may be related to the onset of ONJ. Osteonecrosis appears to occur when the bone tissue of the jaw fails to heal properly from any trauma that causes the jawbone to be exposed in the mouth. For example, this type of exposure can occur from something as simply as a tooth extraction. Once the jawbone begins to die, treatment generally focuses on eradicating infection and relieving pain. More aggressive treatments may include removing large portions of dead bone. The development of Osteonecrosis is associated with the use of Fosamax or other bisphosphonates.

Subsequent studies now suggested that Fosamax and other bisphoshonates might also lead to a breakdown and deterioration of bone tissue in the knee shoulder joints.

FLORIDA WOMAN AWARDED $8 MILLION FOR FOSAMAX® INJURIES

In 2010, a NYC jury awarded a Fosamax® user $8 million, finding that Fosamax® caused her ONJ. The case is In re Fosamax Products Liability Litigation, U.S. District Court, Southern District of New York (Manhattan), No. 06-1789.

FDA SAFETY WARNINGS

At the present time, FDA has not seen fit to issue a nationwide recall of Fosamax® or any of its generic equivalents and the drugs still remains commercially available. However, the FDA has issued numerous other warnings and consumer safety communications regarding bisphosphonates.

Fosamax® is a registered trademark of Merck & Co., Inc.

 

 September 16, 2020

Four Teen Victims Seek $16 Million in Arizona Child Abuse Case

A team of Burg Simpson attorneys including Scott Eldredge, Seth Katz, Ty Taber, Paul Friedman, and Christopher Post along with Tucson-based victims’ rights attorney, Lynne Cadigan, is representing four adoptive children who are named as victims in $16 million child abuse cases filed in Arizona. The children allege they were subjected to aggravated assault and… Read more »

 September 8, 2020

Former Burg Simpson Scholarship Winner is Using Her Funds Wisely!

Ms. McKenna Gilbreth is one of the previous winners of Burg Simpson’s annual scholarship. McKenna recently wrote to Mr. Michael S. Burg, Burg Simpson’s founder, to thank him and to share how she is using her scholarship funds. Now attending Southern Methodist University in Dallas, TX, McKenna wrote from her dorm room that despite the… Read more »

 September 3, 2020

September 2020 E-News

Congratulations to Our Best Lawyers in America® Forty-seven Burg Simpson attorneys have been recognized in the 2021 edition of Best Lawyers in America ®. (33 “Best Lawyers” and 14 “Ones to Watch.”) See the list of Burg Simpson attorneys selected to the 2021 Best Lawyers in America ® here. Three Burg Simpson Lawyers Also Named Best… Read more »

 August 27, 2020

Burg Simpson’s Colorado Scholarship Competition 2020-2021

Burg Simpson has always recognized the importance of access to a strong education. Starting in 2012, we launched the Burg Simpson Scholarship Competition. Each year, Colorado high school seniors are encouraged to write and submit a 1,500 word essay on the importance of the civil jury system as the guardian of American rights and liberties… Read more »

Greeley, CO – Two Workers Killed in Work Accident on 1st Ave

 June 19, 2020

David Hersh: COVID-19 and Loss of Business Income

Shareholder David Hersh Discusses COVID-19 and Loss of Business Income  David P. Hersh is a shareholder and co-practice group leader with  Burg Simpson’s business and commercial litigation department.  “I am David Hersh, Co-leader of the Commercial Litigation Department at Burg Simpson. Business owners across the country have suffered from the loss of business income as… Read more »

David TeSelle Discusses Qui Tam Lawsuits

 June 18, 2020

David TeSelle Discusses Qui Tam Lawsuits

David K. TeSelle is a trial lawyer and co-practice group leader with  Burg Simpson’s business and commercial litigation department.  “Do you have confidential information about a company who is cheating the state or federal government out of money, leaving the American taxpayer holding the bag? If so, there is something you can do about it,… Read more »

 June 16, 2020

Shareholder Jacob Burg Discusses Burg Simpson’s Commitment to Pro Bono Work

Jake Burg is a shareholder and a trial lawyer with  Burg Simpson’s personal injury department. “Since the firm’s inception in 1976, Burg Simpson has been committed to providing pro bono legal services to heroes who have dedicated themselves to serving others in times of great need. As an attorney with Burg Simpson, I was proud to… Read more »

Denver, CO – Two Injured in Motorcycle Accident on I-25 (CanAm Highway)

 June 15, 2020

Injured in a Motorcycle Crash? Call Burg Simpson Now

Injured in a Motorcycle Crash? Call Burg Simpson Now Shareholder Stephen J. Burg is a trial lawyer and the practice group leader of the firm’s personal injury department. If you, or someone you know, has been injured in a motorcycle crash, you need someone to be on your side. Insurance companies make huge profits by… Read more »

Top 100 National Trial Lawyers Legal 500 Best Lawyers in America Super Lawyers US News 2020 Top 25 Most Influential Lawyers